Fujian Yuanxiang New Materials Co.,Ltd (SHE:301300)
39.37
-0.29 (-0.73%)
At close: May 19, 2026
SHE:301300 Revenue
Fujian Yuanxiang New Materials Co.,Ltd had revenue of 118.43M CNY in the quarter ending March 31, 2026, with 6.50% growth. This brings the company's revenue in the last twelve months to 520.88M, up 7.97% year-over-year. In the year 2025, Fujian Yuanxiang New Materials Co.,Ltd had annual revenue of 513.65M with 8.98% growth.
Revenue (ttm)
520.88M
Revenue Growth
+7.97%
P/S Ratio
4.79
Revenue / Employee
1.42M
Employees
368
Market Cap
2.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 513.65M | 42.31M | 8.98% |
| Dec 31, 2024 | 471.34M | 77.52M | 19.68% |
| Dec 31, 2023 | 393.83M | 26.85M | 7.32% |
| Jan 1, 2023 | 366.98M | -37.97M | -9.38% |
| Jan 1, 2022 | 404.95M | 83.76M | 26.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maoming Petro-Chemical Shihua | 3.15B |
| Daqing Huake Company | 1.78B |
| Jiangsu Aoyang Health Industry Co.ltd. | 1.76B |
| Zhe Jiang Dayang Biotech Group | 1.07B |
| Yangzhou Chenhua New Material | 923.15M |
| Zhejiang Hisun Biomaterials Co.Ltd. | 913.88M |
| Yangfan New Materials (Zhejiang) | 890.72M |
| Zhejiang Benli Technology | 638.51M |